Back to Search
Start Over
Negative Inotropy of the Gastric Proton Pump Inhibitor Pantoprazole in Myocardium From Humans and Rabbits
- Source :
- Circulation. 116:57-66
- Publication Year :
- 2007
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2007.
-
Abstract
- Background— Proton pump inhibitors are used extensively for acid-related gastrointestinal diseases. Their effect on cardiac contractility has not been assessed directly. Methods and Results— Under physiological conditions (37°C, pH 7.35, 1.25 mmol/L Ca 2+ ), there was a dose-dependent decrease in contractile force in ventricular trabeculae isolated from end-stage failing human hearts superfused with pantoprazole. The concentration leading to 50% maximal response was 17.3±1.3 μg/mL. Similar observations were made in trabeculae from human atria, normal rabbit ventricles, and isolated rabbit ventricular myocytes. Real-time polymerase chain reaction demonstrated the expression of gastric H + /K + –adenosine triphosphatase in human and rabbit myocardium. However, measurements with BCECF-loaded rabbit trabeculae did not reveal any significant pantoprazole-dependent changes of pH i . Ca 2+ transients recorded from field-stimulated fluo 3–loaded myocytes (F/F 0 ) were significantly depressed by 10.4±2.1% at 40 μg/mL. Intracellular Ca 2+ fluxes were assessed in fura 2–loaded, voltage-clamped rabbit ventricular myocytes. Pantoprazole (40 μg/mL) caused an increase in diastolic [Ca 2+ ] i by 33±12%, but peak systolic [Ca 2+ ] i was unchanged, resulting in a decreased Ca 2+ transient amplitude by 25±8%. The amplitude of the L-type Ca 2+ current ( I Ca,L ) was reduced by 35±5%, and sarcoplasmic reticulum Ca 2+ content was reduced by 18±6%. Measurements of oxalate-supported sarcoplasmic reticulum Ca 2+ uptake in permeabilized cardiomyocytes indicated that pantoprazole decreased Ca 2+ sensitivity (K d ) of sarcoplasmic reticulum Ca 2+ adenosine triphosphatase: control, K d =358±15 nmol/L; 40 μg/mL pantoprazole, K d =395±12 nmol/L ( P 2+ -activated force. Conclusions— Pantoprazole depresses cardiac contractility in vitro by depression of Ca 2+ signaling and myofilament activity. In view of the extensive use of this agent, the effects should be evaluated in vivo.
- Subjects :
- Patch-Clamp Techniques
030204 cardiovascular system & hematology
Polymerase Chain Reaction
2-Pyridinylmethylsulfinylbenzimidazoles
0302 clinical medicine
Diastole
Medicine
Myocyte
Myocytes, Cardiac
Pantoprazole
Oxalates
Aniline Compounds
Lagomorpha
Voltage-dependent calcium channel
biology
Hydrogen-Ion Concentration
Proton Pumps
Fluoresceins
Proton pump
Actin Cytoskeleton
Sarcoplasmic Reticulum
Depression, Chemical
Female
030211 gastroenterology & hepatology
Rabbits
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Calcium Channels, L-Type
Systole
Heart Ventricles
In Vitro Techniques
H(+)-K(+)-Exchanging ATPase
Contractility
03 medical and health sciences
Physiology (medical)
Internal medicine
Animals
Humans
Calcium Signaling
Heart Atria
Fluorescent Dyes
Heart Failure
Ion Transport
business.industry
Myocardium
Proton Pump Inhibitors
Anti-Ulcer Agents
biology.organism_classification
Myocardial Contraction
Endocrinology
Xanthenes
Calcium
Triphosphatase
business
Subjects
Details
- ISSN :
- 15244539 and 00097322
- Volume :
- 116
- Database :
- OpenAIRE
- Journal :
- Circulation
- Accession number :
- edsair.doi.dedup.....e0a0b690865c763fffa88c5731a90553
- Full Text :
- https://doi.org/10.1161/circulationaha.106.666008